AGTR1 and acute respiratory distress syndrome: While the angiotensin-II/type-1 receptor (AT1R) signaling axis has well established pro-inflammatory effects in chronic cardiorenovascular disease that could theoretically worsen ARDS, a randomized trial in critically-ill COVID-19 patients ended enrollment early due to high probability that RAS-inhibition caused harm [5].